Sandbox/table: Difference between revisions
< Sandbox
No edit summary |
|||
(12 intermediate revisions by the same user not shown) | |||
Line 2: | Line 2: | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | {| style="border: 0px; font-size: 90%; margin: 3px;" align=center | ||
! style="width: 500px;background: #4479BA"|{{fontcolor|#FFF| ''''' | ! style="width: 500px;background: #4479BA"|{{fontcolor|#FFF| '''''Alterations in the coagulation system'''''}} | ||
|- | |- | ||
| style="width: 120px;background: #F5F5F5"| | | style="width: 120px;background: #F5F5F5"| Consumption of [[clotting factors]] | ||
|- | |- | ||
| style="width: 120px;background: #DCDCDC"| | | style="width: 120px;background: #DCDCDC"| Increased concentrations of [[fibrin]] degradation products | ||
|- | |- | ||
| style="width: 120px;background: #F5F5F5"| | | style="width: 120px;background: #F5F5F5"| '''[[Disseminated intravascular coagulation]]''' | ||
|- | |- | ||
| | |} | ||
==table== | |||
{| style="border: 2px solid #DCDCDC; font-size: 90%; width: 100%;" | |||
|+ '''Differential Diagnosis of Measles''' | |||
|- | |||
! style="width: 200px; background: #4479BA; text-align: center;"|{{fontcolor|#FFF|Disease}} | |||
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Agent}} | |||
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Typical Season}} | |||
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Typical Age}} | |||
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Prodrome}} | |||
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Fever}} | |||
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Duration of the rash (days)}} | |||
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Rash}} | |||
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Other Signs & Symptoms}} | |||
|- | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Measles''' | |||
| style="background: #DCDCDC; padding: 5px;"| Paramyxovirus<br>Measles virus | |||
| style="background: #F5F5F5; padding: 5px;"| Winter - Spring | |||
| style="background: #DCDCDC; padding: 5px;"| 1 to 20 years | |||
| style="background: #F5F5F5; padding: 5px;"| 2-4 days of cough, conjuctivitis, and coryza | |||
| style="background: #DCDCDC; padding: 5px;"| High | |||
| style="background: #F5F5F5; padding: 5px;"| 5 - 6 | |||
| style="background: #DCDCDC; padding: 5px;"| Erythematous, irregular size, maculopapular; starts on temples & behind ears; progresses down from face; fades to brownish | |||
| style="background: #F5F5F5; padding: 5px;"| Koplik’s spots: C blue-white papules (salt grains) on bright red mucosa opposite premolar teeth | |||
|- | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Kawasaki disease''' | |||
| style="background: #DCDCDC; padding: 5px;"| Unknown | |||
| style="background: #F5F5F5; padding: 5px;"| Winter - Spring | |||
| style="background: #DCDCDC; padding: 5px;"| < 5 years | |||
| style="background: #F5F5F5; padding: 5px;"| 3 days of abrupt fever | |||
| style="background: #DCDCDC; padding: 5px;"| High; fever of 5 days is a diagnostic criteria | |||
| style="background: #F5F5F5; padding: 5px;"| 5 - 7 | |||
| style="background: #DCDCDC; padding: 5px;"| Erythematous, morbilliform, maculopapular or scarlatiniform, central distribution; erythematous, indurated palms and soles | |||
| style="background: #F5F5F5; padding: 5px;"| Acute: dry, fissured and injected lips, strawberry tongue; irritability; cervical lymphadenopathy; conjunctival injection; peripheral edema Subacute: finger-tip desquamation; Complications: arthritis, carditis | |||
|- | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Roseola Infantum (exanthem subitum)''' | |||
| style="background: #DCDCDC; padding: 5px;"| Human herpes virus type 6 | |||
| style="background: #F5F5F5; padding: 5px;"| Any season | |||
| style="background: #DCDCDC; padding: 5px;"| 6 months to 2 years | |||
| style="background: #F5F5F5; padding: 5px;"| None | |||
| style="background: #DCDCDC; padding: 5px;"| High | |||
| style="background: #F5F5F5; padding: 5px;"| 1-2; it follows defervescence | |||
| style="background: #DCDCDC; padding: 5px;"| Discrete erythematous macules, rarely involves face, begins as fever ends | |||
| style="background: #F5F5F5; padding: 5px;"| Lymphadenopathy, irritability | |||
|- | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Rubella''' | |||
| style="background: #DCDCDC; padding: 5px;"| Togavirus | |||
| style="background: #F5F5F5; padding: 5px;"| Spring | |||
| style="background: #DCDCDC; padding: 5px;"| 7 months to 29 years | |||
| style="background: #F5F5F5; padding: 5px;"| 0 - 4 days; mild malaise, fever; absent in children | |||
| style="background: #DCDCDC; padding: 5px;"| Low grade | |||
| style="background: #F5F5F5; padding: 5px;"| 1 - 3 | |||
| style="background: #DCDCDC; padding: 5px;"| Discrete, rose-pink, diffuse, maculopapular; progresses downward from face, may change quickly | |||
| style="background: #F5F5F5; padding: 5px;"| Arthralgia (usually in adults), tender posterior cervical and suboccipital lymphadenopathy, malaise, petechiae on soft palate | |||
|- | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Scarlet Fever''' | |||
| style="background: #DCDCDC; padding: 5px;"| ß-hemolytic [[streptococci]] | |||
| style="background: #F5F5F5; padding: 5px;"| Winter | |||
| style="background: #DCDCDC; padding: 5px;"| > 2 years | |||
| style="background: #F5F5F5; padding: 5px;"| 0 - 6 day, marked | |||
| style="background: #DCDCDC; padding: 5px;"| Low to high | |||
| style="background: #F5F5F5; padding: 5px;"| 2 - 7 | |||
| style="background: #DCDCDC; padding: 5px;"| Scarlet "sunburn" with punctate papules "sandpaper", circumoral pallor, increased intensity in skin folds, blanches stars face/head, upper trunk and progresses downward | |||
| style="background: #F5F5F5; padding: 5px;"| Sore throat, exudative tonsillitis, vomiting, abdominal pain, lmphadenopathy, white then red strawberry tongue | |||
|- | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Erythema Infectiosum 9Fifth Disease)''' | |||
| style="background: #DCDCDC; padding: 5px;"| Human parvovirus type B19 | |||
| style="background: #F5F5F5; padding: 5px;"| Spring | |||
| style="background: #DCDCDC; padding: 5px;"| 5 - 10 years | |||
| style="background: #F5F5F5; padding: 5px;"| None, usually in children, may occur in adults | |||
| style="background: #DCDCDC; padding: 5px;"| None to low-grade | |||
| style="background: #F5F5F5; padding: 5px;"| 2 - 4 | |||
| style="background: #DCDCDC; padding: 5px;"| Starts as “slapped cheek”, maculopapular; progresses to reticular (lacy) pattern; can recur with environmental changes such as sunlight exposure | |||
| style="background: #F5F5F5; padding: 5px;"| Arthralgia/arthritis in adults, adenopathy | |||
|- | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Enterovirus''' | |||
| style="background: #DCDCDC; padding: 5px;"| Echovirus<br>Coxsackie virus | |||
| style="background: #F5F5F5; padding: 5px;"| Summer - Fall | |||
| style="background: #DCDCDC; padding: 5px;"| Mainly childhood | |||
| style="background: #F5F5F5; padding: 5px;"| 0 - 1 day fever and myalias | |||
| style="background: #DCDCDC; padding: 5px;"| Low to high | |||
| style="background: #F5F5F5; padding: 5px;"| 1 - 5 | |||
| style="background: #DCDCDC; padding: 5px;"| Fine, pink, always affects face; variant is Boston exanthem (large ~ 1 cm, discrete maculopapules) | |||
| style="background: #F5F5F5; padding: 5px;"| Sore throat, headache, malaise, no lymphadenopathy, gastroenteritis | |||
|- | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Dengue Fever''' | |||
| style="background: #DCDCDC; padding: 5px;"| Flavivirus<br>Dengue virus types 1 - 4 | |||
| style="background: #F5F5F5; padding: 5px;"| | |||
| style="background: #DCDCDC; padding: 5px;"| | |||
| style="background: #F5F5F5; padding: 5px;"| None | |||
| style="background: #DCDCDC; padding: 5px;"| High | |||
| style="background: #F5F5F5; padding: 5px;"|1 - 5 | |||
| style="background: #DCDCDC; padding: 5px;"| Generalized maculopapular rash after defervescence; spares palms and soles | |||
| style="background: #F5F5F5; padding: 5px;"| Headache, myalgia, abdominal pain, pharyngitis, vomiting | |||
|- | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Drug induced rash''' | |||
| style="background: #DCDCDC; padding: 5px;"| Many | |||
| style="background: #F5F5F5; padding: 5px;"| Any | |||
| style="background: #DCDCDC; padding: 5px;"| Any | |||
| style="background: #F5F5F5; padding: 5px;"|Possible due to underlying illness | |||
| style="background: #DCDCDC; padding: 5px;"| Possible | |||
| style="background: #F5F5F5; padding: 5px;"| Varies | |||
| style="background: #DCDCDC; padding: 5px;"| Typically diffuse but may be concentrated in diaper area, typically no progression, erythema multiform rash can progress over a few days | |||
| style="background: #F5F5F5; padding: 5px;"| Possibly due to underlying illness or complications | |||
|- | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Infectious Mononucleosis''' | |||
| style="background: #DCDCDC; padding: 5px;"| Epstein-Barr Virus | |||
| style="background: #F5F5F5; padding: 5px;"| None | |||
| style="background: #DCDCDC; padding: 5px;"| 10 - 30 years | |||
| style="background: #F5F5F5; padding: 5px;"| 2 - 5 days of malaise and fatigue | |||
| style="background: #DCDCDC; padding: 5px;"| Low to high | |||
| style="background: #F5F5F5; padding: 5px;"| 2 - 7 | |||
| style="background: #DCDCDC; padding: 5px;"| Trunk and proximal extremities. Rash common if Ampicillin given | |||
| style="background: #F5F5F5; padding: 5px;"| Pharyngitis, lymphadenopathy, splenomegaly, malaise | |||
|- | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Pharyngoconjunctival Fever''' | |||
| style="background: #DCDCDC; padding: 5px;"| Adenovirus types 2, 3, 4, 7, 7a | |||
| style="background: #F5F5F5; padding: 5px;"| Winter - Spring | |||
| style="background: #DCDCDC; padding: 5px;"| < 5 years | |||
| style="background: #F5F5F5; padding: 5px;"| | |||
| style="background: #DCDCDC; padding: 5px;"| Low to high | |||
| style="background: #F5F5F5; padding: 5px;"| 3 - 5 | |||
| style="background: #DCDCDC; padding: 5px;"| Starts on face and spreads down to trunk and extremities | |||
| style="background: #F5F5F5; padding: 5px;"| Sore throat, conjunctivitis, headache, anorexia | |||
|} | |||
==table== | |||
{| style="border: 2px solid #DCDCDC; font-size: 90%; width: 80%;" | |||
|+ '''Countries with a reported prevalence <15% of ''H. pylori'' resistance to clarithromycin''' | |||
! style="background: #DCDCDC;" | Diagnostic test | |||
! style="background: #DCDCDC;" | North America | |||
! style="background: #DCDCDC;" | South America | |||
! style="background: #DCDCDC;" | Middle East | |||
! style="background: #DCDCDC;" | Far East | |||
|- | |- | ||
| style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top | [[ELISA]] (serology) detects: | |||
* Viral Antigen | |||
* IgM and IgG antibody | hol | |||
| style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top | | |||
| style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top | | |||
| style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top | | |||
| style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top | | |||
|} | |} | ||
<SMALL><sup>†</sup> There is a reported prevalence of 15% in the Northeast of the US.</SMALL> | |||
==table== | |||
{| style="font-size: | {| style="border: 2px solid #DCDCDC; font-size: 90%; width: 70%;" | ||
! style="width: | |+ '''Natural History of Dengue Fever''' | ||
! style="width: | |- | ||
! style="width: 100px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Phase}} | |||
! style="width: 100px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Days}} | |||
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Characterized by}} | |||
|- | |||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Incubation period''' | |||
| style="background: #DCDCDC; padding: 5px;"| 4 - 10 days | |||
| style="background: #F5F5F5; padding: 5px;"| No symptoms | |||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| ''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Febrile phase''' | ||
| style="background: #DCDCDC; padding: 5px;"| | | style="background: #DCDCDC; padding: 5px;"| 2 - 7 days | ||
| style="background: #F5F5F5; padding: 5px;"| High-grade [[fever]], [[facial flushing]], skin [[erythema]], generalized [[body ache]], [[myalgia]], [[arthralgia]], [[headache]], [[anorexia]] [[nausea]] and [[vomiting]]. Mild haemorrhagic manifestations such as [[petechiae]] and mucosal membrane bleeding | |||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| ''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Critical phase''' | ||
| style="background: #DCDCDC; padding: 5px;"| | | style="background: #DCDCDC; padding: 5px;"| | ||
| style="background: #F5F5F5; padding: 5px;"| | |||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| ''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Recovery phase''' | ||
| style="background: #DCDCDC; padding: 5px;"| | | style="background: #DCDCDC; padding: 5px;"| | ||
| style="background: #F5F5F5; padding: 5px;"| | |||
|- | |- | ||
|} | |} |
Latest revision as of 18:33, 26 June 2014
The following table contains the main risk factors for CDI:[1][2][3][2][2]
Alterations in the coagulation system |
---|
Consumption of clotting factors |
Increased concentrations of fibrin degradation products |
Disseminated intravascular coagulation |
table
Disease | Agent | Typical Season | Typical Age | Prodrome | Fever | Duration of the rash (days) | Rash | Other Signs & Symptoms |
---|---|---|---|---|---|---|---|---|
Measles | Paramyxovirus Measles virus |
Winter - Spring | 1 to 20 years | 2-4 days of cough, conjuctivitis, and coryza | High | 5 - 6 | Erythematous, irregular size, maculopapular; starts on temples & behind ears; progresses down from face; fades to brownish | Koplik’s spots: C blue-white papules (salt grains) on bright red mucosa opposite premolar teeth |
Kawasaki disease | Unknown | Winter - Spring | < 5 years | 3 days of abrupt fever | High; fever of 5 days is a diagnostic criteria | 5 - 7 | Erythematous, morbilliform, maculopapular or scarlatiniform, central distribution; erythematous, indurated palms and soles | Acute: dry, fissured and injected lips, strawberry tongue; irritability; cervical lymphadenopathy; conjunctival injection; peripheral edema Subacute: finger-tip desquamation; Complications: arthritis, carditis |
Roseola Infantum (exanthem subitum) | Human herpes virus type 6 | Any season | 6 months to 2 years | None | High | 1-2; it follows defervescence | Discrete erythematous macules, rarely involves face, begins as fever ends | Lymphadenopathy, irritability |
Rubella | Togavirus | Spring | 7 months to 29 years | 0 - 4 days; mild malaise, fever; absent in children | Low grade | 1 - 3 | Discrete, rose-pink, diffuse, maculopapular; progresses downward from face, may change quickly | Arthralgia (usually in adults), tender posterior cervical and suboccipital lymphadenopathy, malaise, petechiae on soft palate |
Scarlet Fever | ß-hemolytic streptococci | Winter | > 2 years | 0 - 6 day, marked | Low to high | 2 - 7 | Scarlet "sunburn" with punctate papules "sandpaper", circumoral pallor, increased intensity in skin folds, blanches stars face/head, upper trunk and progresses downward | Sore throat, exudative tonsillitis, vomiting, abdominal pain, lmphadenopathy, white then red strawberry tongue |
Erythema Infectiosum 9Fifth Disease) | Human parvovirus type B19 | Spring | 5 - 10 years | None, usually in children, may occur in adults | None to low-grade | 2 - 4 | Starts as “slapped cheek”, maculopapular; progresses to reticular (lacy) pattern; can recur with environmental changes such as sunlight exposure | Arthralgia/arthritis in adults, adenopathy |
Enterovirus | Echovirus Coxsackie virus |
Summer - Fall | Mainly childhood | 0 - 1 day fever and myalias | Low to high | 1 - 5 | Fine, pink, always affects face; variant is Boston exanthem (large ~ 1 cm, discrete maculopapules) | Sore throat, headache, malaise, no lymphadenopathy, gastroenteritis |
Dengue Fever | Flavivirus Dengue virus types 1 - 4 |
None | High | 1 - 5 | Generalized maculopapular rash after defervescence; spares palms and soles | Headache, myalgia, abdominal pain, pharyngitis, vomiting | ||
Drug induced rash | Many | Any | Any | Possible due to underlying illness | Possible | Varies | Typically diffuse but may be concentrated in diaper area, typically no progression, erythema multiform rash can progress over a few days | Possibly due to underlying illness or complications |
Infectious Mononucleosis | Epstein-Barr Virus | None | 10 - 30 years | 2 - 5 days of malaise and fatigue | Low to high | 2 - 7 | Trunk and proximal extremities. Rash common if Ampicillin given | Pharyngitis, lymphadenopathy, splenomegaly, malaise |
Pharyngoconjunctival Fever | Adenovirus types 2, 3, 4, 7, 7a | Winter - Spring | < 5 years | Low to high | 3 - 5 | Starts on face and spreads down to trunk and extremities | Sore throat, conjunctivitis, headache, anorexia |
table
Diagnostic test | North America | South America | Middle East | Far East |
---|---|---|---|---|
ELISA (serology) detects:
|
† There is a reported prevalence of 15% in the Northeast of the US.
table
Phase | Days | Characterized by |
---|---|---|
Incubation period | 4 - 10 days | No symptoms |
Febrile phase | 2 - 7 days | High-grade fever, facial flushing, skin erythema, generalized body ache, myalgia, arthralgia, headache, anorexia nausea and vomiting. Mild haemorrhagic manifestations such as petechiae and mucosal membrane bleeding |
Critical phase | ||
Recovery phase |
- ↑ Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ (2012). "Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics". J Antimicrob Chemother. 67 (3): 742–8. doi:10.1093/jac/dkr508. PMID 22146873.
- ↑ 2.0 2.1 2.2 Knight, Christopher L.; Surawicz, Christina M. (2013). "Clostridium difficile Infection". Medical Clinics of North America. 97 (4): 523–536. doi:10.1016/j.mcna.2013.02.003. ISSN 0025-7125.
- ↑ Planche, Tim (2013). "Clostridium difficile". Medicine. 41 (11): 654–657. doi:10.1016/j.mpmed.2013.08.003. ISSN 1357-3039.